BeOne Medicines Ltd
220 hedge funds and large institutions have $9.45B invested in BeOne Medicines Ltd in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 98 increasing their positions, 64 reducing their positions, and 23 closing their positions.
56% more call options, than puts
Call options by funds: $13.2M | Put options by funds: $8.42M
56% more capital invested
Capital invested by funds: $6.06B → $9.45B (+$3.39B)
53% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 64
26% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 23
2% more funds holding
Funds holding: 215 → 220 (+5)
0.08% more ownership
Funds ownership: 4.92% → 5% (+0.08%)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$40.2M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$34.5M |
| 3 |
Temasek Holdings
Singapore
|
+$32.9M |
| 4 |
AG
Artal Group
Luxembourg
|
+$32.6M |
| 5 |
BlackRock
New York
|
+$30.9M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$44.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$19.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$14M |
| 4 |
State Street
Boston,
Massachusetts
|
-$11.3M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$10.9M |
ONC Hedge Fund Activity: Q2 2020 in Review
220 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q2 2020, worth a combined $9.45B — up 56% from $6.06B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new ONC positions and 23 closed out — a net gain of 6 holders — while 98 added to existing stakes and 64 trimmed.
The largest buyer was Capital International Investors, adding an estimated $40.2M. The largest seller was Fidelity Investments, cutting an estimated $44.4M.
- 220 institutional investors held BeOne Medicines Ltd (ONC) as of Q2 2020, up from 215 in Q1 2020.
- Funds reported $9.45B of BeOne Medicines Ltd stock for Q2 2020, up 56% quarter-over-quarter.
- 29 funds opened new BeOne Medicines Ltd positions in Q2 2020 and 23 closed out, a net change of +6 holders.
- The largest BeOne Medicines Ltd buyer in Q2 2020 was Capital International Investors, an estimated $40.2M added.
- The largest BeOne Medicines Ltd seller in Q2 2020 was Fidelity Investments, an estimated $44.4M sold.
Based on aggregated 13F filings for Q2 2020.